Riding the Wave: Clinical Management of Myeloid Malignancies In an Era of Novel Therapies
Friday, November 30, 2018 – 7:00-11:00 am
Manchester Grand Hyatt San Diego, Coronado ABC
San Diego, CA
Satellite Symposium organized by the Cleveland Clinic Taussig Cancer Institute Leukemia Program and the Aplastic Anemia and MDS International Foundation, preceding the 60th ASH Annual Meeting.
This CME certified activity will provide an in-depth and up-to-date review of research related to the biology, prognosis, natural history, and therapeutic management of patients with MDS, PHN, AML and myeloid malignancies. The overall goal of the program is to bring together leaders in disease research and clinical practice to explore solutions to improving the care of these patient populations.
Supported by an independent educational grant from Celgene Corporation, Takeda Oncology, Alexion, Apellis, Onconova Therapeutics and Ra Pharma, Geron
Lymphoma & Myeloma Congress
October 17-20, 2018
New York, NY
The Lymphoma & Myeloma Congress, an international conference on hematologic malignancies, will be taking place October 17-20 in New York City. This 1,000+ person meeting is meant for all healthcare professionals involved with or interested in the treatment of different blood cancers. Now in its 18th year, the Lymphoma & Myeloma Congress is recognized around the world as the most respected forum for industry-leading hematologic research.
New for this year, the meeting has added a fourth day specifically focused on “New Approaches in Acute Leukemia & Hematologic Malignancies,” taking place on October 17. Concurrent Nurse Practitioner and Physician Assistant sessions (in addition to all other regularly scheduled courses) will take place October 18-20. For more information, visit www.lymphomaandmyeloma.com.
International Scientific Symposium 2018
March 22 – 23, 2018
AAMDSIF sponsored its sixth International Bone Marrow Failure Disease Scientific Symposium in March 22-23, 2018, in Rockville, Maryland. The Symposium brought together physicians treating these diseases; laboratory researchers studying the genetics, genomics, and pathophysiology of bone marrow failure; and clinical investigators to discuss current areas of consensus and controversy, share recent research results, and identify the highest-priority directions for basic and clinical research to advance the field.
Regional Bone Marrow Failure Disease Symposia
Clinicians caring for both children and adults are frequently faced with patients with low blood counts and the challenge of initial management and work-up. This symposium will provide participants with the most up-to-date review of scientific and clinical research related to the biology and management of pediatric and adult bone marrow failure diseases, including anemia, myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), and paroxysmal nocturnal hemoglobinuria (PNH). The presenters will focus on the latest advances in the diagnosis, genetic characteristics, pathology and treatment options for these diseases, including the importance of recognizing adult presentations of inherited marrow failure syndromes and recent discoveries in inherited bone marrow failure defects.
- 2019 dates to be announced soon
MDS Rounds: An AAMDSIF Visiting Faculty Program
The CME/CE-accredited MDS Rounds Program provides a forum for health care professionals who care for patients with bone marrow failure disorders to address issues related to the diagnosis and treatment of patients with myelodysplastic syndromes (MDS). Participants will learn the latest information on new therapies and advances in the management of MDS through lecture and case studies developed and presented by an expert in hematology/oncology.
Designed for a standard one-hour program format, this program has been developed by the Aplastic Anemia and MDS International Foundation (AAMDSIF) and accredited by USF Health. It is available at no charge for medical centers to provide for the professional staff.